Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis : Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)
Copyright © 2018 Elsevier B.V. All rights reserved..
PURPOSE: ULISSE is the only study that prospectively assessed the efficiency of a standardized strategy, compared to an open strategy for the etiologic diagnosis of uveitis. Our aim was to evaluate the diagnostic yield of the tests prescribed in the ULISSE study to clarify their relevance.
METHODS: ULISSE is a non-inferiority, prospective, multicenter and cluster randomized study. The standardized strategy is a two-steps strategy: in the first step, common standard tests were performed, and in the second step, tests were guided by the clinical and anatomic type of uveitis. We reported the relevance of the diagnostic tests used in the standardized strategy, as well as the profitability of the tests that were prescribed to more than twenty patients in each group. Based on diagnostic criteria, either an ophthalmologist, or an internist, established the profitability of a test by considering whether the test lead to a diagnosis or not.
RESULTS: Among the 676 patients included (standardized 303; open 373), a diagnosis was made for 152 (50.4%) in the standardized group and 203 (54.4%) in the open group. The most common entities were HLA-B27 associated uveitis (22%), spondyloarthritis (11%), sarcoidosis (18%), tuberculosis (10.7%) and herpes virus infections (8.5%). Among the first step's systematic tests, tuberculin skin test was the most contributive investigation (17.1%), followed by chest X-ray (8.4%), C reactive protein and ESR (6.6% and 5.1%), complete blood count (2.2%) and VDRL (2.0%). The second step's most often contributive tests were: HLA B27 (56.3%), chest-CT (30.3%) and angiotensin converting enzyme (ACE) (16.5%). HLA B27 and ACE were significantly more contributive in the standardized group than in the open group. Immunological tests were never contributive. Among the free investigations, or among the investigations guided by clinical or paraclinical findings, the most often contributive tests were: Quantiferon® (24%), electrophoresis of serum protein (7.8%) and sacroiliac imagery (46.4%). Intracellular serologies (1.7%), serum calcium (2.1%) and hepatic tests (3.3%) were exceptionally contributive. Among the third intention tests, labial salivary gland biopsies were contributive in 17.9% of cases, but the profitability of other invasive investigations (anterior chamber tap, vitrectomy, bronchoscopy and lumbar puncture) or specialized imagery (18F-FDG PET, Brain MRI) could not be determined since these test were rarely performed.
CONCLUSION: Only a few diagnostic tests are useful for the etiological assessment of uveitis. They are often cheap, simple, more often guided by the clinical findings, and lead to an etiological diagnosis in most patients. On the other hand, some tests are never or exceptionally contributive, such as immunological tests or intracellular serologies. Further studies are required to evaluate the profitability of third intention imagery and invasive investigations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Autoimmunity reviews - 17(2018), 4 vom: 15. Apr., Seite 331-343 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Diagnosis |
|---|
| Anmerkungen: |
Date Completed 29.05.2018 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.autrev.2017.10.018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM280869606 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM280869606 | ||
| 003 | DE-627 | ||
| 005 | 20231225030322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.autrev.2017.10.018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0936.xml |
| 035 | |a (DE-627)NLM280869606 | ||
| 035 | |a (NLM)29427823 | ||
| 035 | |a (PII)S1568-9972(18)30030-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grumet, Pierre |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis |b Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis) |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.05.2018 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 Elsevier B.V. All rights reserved. | ||
| 520 | |a PURPOSE: ULISSE is the only study that prospectively assessed the efficiency of a standardized strategy, compared to an open strategy for the etiologic diagnosis of uveitis. Our aim was to evaluate the diagnostic yield of the tests prescribed in the ULISSE study to clarify their relevance | ||
| 520 | |a METHODS: ULISSE is a non-inferiority, prospective, multicenter and cluster randomized study. The standardized strategy is a two-steps strategy: in the first step, common standard tests were performed, and in the second step, tests were guided by the clinical and anatomic type of uveitis. We reported the relevance of the diagnostic tests used in the standardized strategy, as well as the profitability of the tests that were prescribed to more than twenty patients in each group. Based on diagnostic criteria, either an ophthalmologist, or an internist, established the profitability of a test by considering whether the test lead to a diagnosis or not | ||
| 520 | |a RESULTS: Among the 676 patients included (standardized 303; open 373), a diagnosis was made for 152 (50.4%) in the standardized group and 203 (54.4%) in the open group. The most common entities were HLA-B27 associated uveitis (22%), spondyloarthritis (11%), sarcoidosis (18%), tuberculosis (10.7%) and herpes virus infections (8.5%). Among the first step's systematic tests, tuberculin skin test was the most contributive investigation (17.1%), followed by chest X-ray (8.4%), C reactive protein and ESR (6.6% and 5.1%), complete blood count (2.2%) and VDRL (2.0%). The second step's most often contributive tests were: HLA B27 (56.3%), chest-CT (30.3%) and angiotensin converting enzyme (ACE) (16.5%). HLA B27 and ACE were significantly more contributive in the standardized group than in the open group. Immunological tests were never contributive. Among the free investigations, or among the investigations guided by clinical or paraclinical findings, the most often contributive tests were: Quantiferon® (24%), electrophoresis of serum protein (7.8%) and sacroiliac imagery (46.4%). Intracellular serologies (1.7%), serum calcium (2.1%) and hepatic tests (3.3%) were exceptionally contributive. Among the third intention tests, labial salivary gland biopsies were contributive in 17.9% of cases, but the profitability of other invasive investigations (anterior chamber tap, vitrectomy, bronchoscopy and lumbar puncture) or specialized imagery (18F-FDG PET, Brain MRI) could not be determined since these test were rarely performed | ||
| 520 | |a CONCLUSION: Only a few diagnostic tests are useful for the etiological assessment of uveitis. They are often cheap, simple, more often guided by the clinical findings, and lead to an etiological diagnosis in most patients. On the other hand, some tests are never or exceptionally contributive, such as immunological tests or intracellular serologies. Further studies are required to evaluate the profitability of third intention imagery and invasive investigations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Etiology | |
| 650 | 4 | |a Recommendations | |
| 650 | 4 | |a Standardized strategy | |
| 650 | 4 | |a Uveitis | |
| 700 | 1 | |a Kodjikian, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a de Parisot, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Errera, Marie-Hélène |e verfasserin |4 aut | |
| 700 | 1 | |a Sedira, Neila |e verfasserin |4 aut | |
| 700 | 1 | |a Heron, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Pérard, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Cornut, Pierre-Loïc |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Christelle |e verfasserin |4 aut | |
| 700 | 1 | |a Rivière, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Ollé, Priscille |e verfasserin |4 aut | |
| 700 | 1 | |a Pugnet, Grégory |e verfasserin |4 aut | |
| 700 | 1 | |a Cathébras, Pascal |e verfasserin |4 aut | |
| 700 | 1 | |a Manoli, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Bodaghi, Bahram |e verfasserin |4 aut | |
| 700 | 1 | |a Saadoun, David |e verfasserin |4 aut | |
| 700 | 1 | |a Baillif, Stéphanie |e verfasserin |4 aut | |
| 700 | 1 | |a Tieulie, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Andre, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Chiambaretta, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Bonin, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Bielefeld, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Bron, Alain |e verfasserin |4 aut | |
| 700 | 1 | |a Mouriaux, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Bienvenu, Boris |e verfasserin |4 aut | |
| 700 | 1 | |a Vicente, Stéphanie |e verfasserin |4 aut | |
| 700 | 1 | |a Bin, Sylvie |e verfasserin |4 aut | |
| 700 | 1 | |a Labetoulle, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Broussolle, Christiane |e verfasserin |4 aut | |
| 700 | 1 | |a Jamilloux, Yvan |e verfasserin |4 aut | |
| 700 | 1 | |a Decullier, Evelyne |e verfasserin |4 aut | |
| 700 | 1 | |a Sève, Pascal |e verfasserin |4 aut | |
| 700 | 0 | |a ULISSE group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Autoimmunity reviews |d 2002 |g 17(2018), 4 vom: 15. Apr., Seite 331-343 |w (DE-627)NLM126096996 |x 1873-0183 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2018 |g number:4 |g day:15 |g month:04 |g pages:331-343 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.autrev.2017.10.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2018 |e 4 |b 15 |c 04 |h 331-343 | ||